Hao‐Lun Luo

1.1k total citations
80 papers, 780 citations indexed

About

Hao‐Lun Luo is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hao‐Lun Luo has authored 80 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Surgery, 29 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hao‐Lun Luo's work include Bladder and Urothelial Cancer Treatments (45 papers), Urinary and Genital Oncology Studies (29 papers) and Urological Disorders and Treatments (9 papers). Hao‐Lun Luo is often cited by papers focused on Bladder and Urothelial Cancer Treatments (45 papers), Urinary and Genital Oncology Studies (29 papers) and Urological Disorders and Treatments (9 papers). Hao‐Lun Luo collaborates with scholars based in Taiwan, United States and China. Hao‐Lun Luo's co-authors include Yao‐Chi Chuang, Po‐Hui Chiang, Yuan‐Tso Cheng, Chun‐Chieh Huang, Yu‐Li Su, Po Hui Chiang, Hung‐Jen Wang, Ming-Tse Sung, Chien‐Hsu Chen and Chih‐Hsiung Kang and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Hao‐Lun Luo

75 papers receiving 776 citations

Peers

Hao‐Lun Luo
Cheol Yong Yoon South Korea
D. Baumunk Germany
Jianhui Shi United States
Cheol Yong Yoon South Korea
Hao‐Lun Luo
Citations per year, relative to Hao‐Lun Luo Hao‐Lun Luo (= 1×) peers Cheol Yong Yoon

Countries citing papers authored by Hao‐Lun Luo

Since Specialization
Citations

This map shows the geographic impact of Hao‐Lun Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao‐Lun Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao‐Lun Luo more than expected).

Fields of papers citing papers by Hao‐Lun Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao‐Lun Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao‐Lun Luo. The network helps show where Hao‐Lun Luo may publish in the future.

Co-authorship network of co-authors of Hao‐Lun Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Hao‐Lun Luo. A scholar is included among the top collaborators of Hao‐Lun Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao‐Lun Luo. Hao‐Lun Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Hui‐Ying, Yao‐Chi Chuang, Yen-Ta Chen, et al.. (2024). Association between Statin Use and Clinical Outcomes in Patients with De Novo Metastatic Prostate Cancer: A Propensity Score-weighted Analysis. The World Journal of Men s Health. 42(3). 630–630.
6.
Huang, Yun‐Ching, Jui‐Ming Liu, Hui‐Ying Liu, et al.. (2023). Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma. Cancers. 15(6). 1858–1858. 2 indexed citations
7.
Su, Yu‐Li, Chia‐Che Wu, Yi‐Hua Chen, et al.. (2023). Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process. Cells. 12(11). 1471–1471. 4 indexed citations
8.
Luo, Hao‐Lun, Hui‐Ying Liu, Ming-Tse Sung, et al.. (2023). VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma. International Journal of Molecular Sciences. 24(8). 7486–7486. 7 indexed citations
9.
Liu, Yiyang, Yen-Ta Chen, Hao‐Lun Luo, et al.. (2022). Totally X-ray-Free Ultrasound-Guided Mini-Percutaneous Nephrolithotomy in Galdakao-Modified Supine Valdivia Position: A Novel Combined Surgery. Journal of Clinical Medicine. 11(22). 6644–6644.
10.
Luo, Hao‐Lun, Hui‐Ying Liu, Ming-Tse Sung, et al.. (2021). Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma. International Journal of Molecular Sciences. 22(16). 8761–8761. 7 indexed citations
12.
Su, Yu‐Li, Hao‐Lun Luo, Chun‐Chieh Huang, et al.. (2020). Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival. Cells. 9(4). 806–806. 33 indexed citations
13.
Lin, Jen‐Jie, Chun‐Chieh Huang, Yu‐Li Su, et al.. (2019). Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells. International Journal of Molecular Sciences. 20(5). 1017–1017. 25 indexed citations
14.
Chen, I‐Hsuan, Hao‐Lun Luo, Yu‐Li Su, et al.. (2019). Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway. Molecules. 24(20). 3707–3707. 10 indexed citations
15.
Luo, Hao‐Lun, et al.. (2019). Preventive Role of mTOR Inhibitor in Post–Kidney Transplant Urothelial Carcinoma. Transplantation Proceedings. 51(8). 2731–2734. 3 indexed citations
16.
Huang, Chun‐Chieh, Yu‐Li Su, Hao‐Lun Luo, et al.. (2019). Gender Is a Significant Prognostic Factor for Upper Tract Urothelial Carcinoma: A Large Hospital-Based Cancer Registry Study in an Endemic Area. Frontiers in Oncology. 9. 157–157. 24 indexed citations
18.
Luo, Hao‐Lun, et al.. (2016). RAPTOR gene polymorphism is independently correlated with urothelial cancer susceptibility compared with environmental toxin exposure. Urological Science. 28(4). 197–199. 1 indexed citations
19.
Luo, Hao‐Lun, et al.. (2012). Lymphovascular invasion is a pathological feature related to aggressive cancer behavior and predicts early recurrence in prostate cancer. The Kaohsiung Journal of Medical Sciences. 28(6). 327–330. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026